E. coli-Produced BMP-2 as a Chemopreventive Strategy for Colon Cancer: A Proof-of-Concept Study

The Potential of Statins for Individualized Colorectal Cancer Chemoprevention

(2011) Rutger J. Jacobs et al.   CURRENT DRUG TARGETS

Statins augment the chemosensitivity of colorectal cancer cells inducing epigenetic reprogramming and reducing colorectal cancer cell 'stemness' via the bone morphogenetic protein pathway

(2011) L. L. Kodach et al.   GUT

Genetically ModifiedLactococcus lactisfor Delivery of Human Interleukin-10 to Dendritic Cells

(2011) Inge L. Huibregtse et al.   Gastroenterology Research and Practice

Bone Morphogenetic Proteins: A critical review

(2010) Beth Bragdon et al.   CELLULAR SIGNALLING

Colon cancer

(2010) Roberto Labianca et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Enteric defensins are essential regulators of intestinal microbial ecology

(2009) Nita H Salzman et al.   NATURE IMMUNOLOGY

The Bone Morphogenetic Protein Pathway Is Inactivated in the Majority of Sporadic Colorectal Cancers

(2008) Liudmila L. Kodach et al.   GASTROENTEROLOGY

Human scFv SIgA expressed onLactococcus lactisas a vector for the treatment of mucosal disease

(2008) Saravanan Yuvaraj et al.   MOLECULAR NUTRITION & FOOD RESEARCH

The bone morphogenetic protein pathway is active in human colon adenomas and inactivated in colorectal cancer

(2007) Liudmila L. Kodach et al.   CANCER